Cite
HARVARD Citation
Miura, K. et al. (2021). Consolidation with 90Yttrium‐ibritumomab tiuxetan after bendamustine and rituximab for relapsed follicular lymphoma. Hematological oncology. 39 (1), pp. 51-59. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Miura, K. et al. (2021). Consolidation with 90Yttrium‐ibritumomab tiuxetan after bendamustine and rituximab for relapsed follicular lymphoma. Hematological oncology. 39 (1), pp. 51-59. [Online].